These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 38613802)
1. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification. Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802 [TBL] [Abstract][Full Text] [Related]
2. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma. Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174 [TBL] [Abstract][Full Text] [Related]
3. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Tao C; Luo H; Chen L; Li J; Zhu X; Huang K Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803 [TBL] [Abstract][Full Text] [Related]
4. Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas. Xu Y; Weng W; Weng Y; Chen D; Zheng Z; Fan Z; Peng C; Xiong Y; Pang X; Cao G; Wang Y; Mo Q; Wang Z; Zhang S Sci Rep; 2024 Jul; 14(1):15758. PubMed ID: 38977800 [TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas. Gao L; Zhang R; Zhang W; Lan Y; Li X; Cai Q; Liu J BMC Cancer; 2024 Oct; 24(1):1252. PubMed ID: 39390437 [TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis. Yang A; Wang X; Hu Y; Shang C; Hong Y Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971 [TBL] [Abstract][Full Text] [Related]
7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
8. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma. Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612 [TBL] [Abstract][Full Text] [Related]
9. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression. Ye T; Cheng Y; Li C Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317 [TBL] [Abstract][Full Text] [Related]
10. Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma. Maimaiti A; Wang X; Hao Y; Jiang L; Shi X; Pei Y; Feng Z; Kasimu M J Mol Neurosci; 2021 Aug; 71(8):1622-1635. PubMed ID: 33713320 [TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis and experimental validation reveal the relationship between ALOX5AP and the prognosis and immune microenvironment in glioma. Song P; Deng H; Liu Y; Zhang M BMC Med Genomics; 2024 Aug; 17(1):218. PubMed ID: 39169376 [TBL] [Abstract][Full Text] [Related]
12. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas. Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682 [TBL] [Abstract][Full Text] [Related]
13. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
14. An integrated transcriptomic and computational analysis for biomarker identification in human glioma. Xing W; Zeng C Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173 [TBL] [Abstract][Full Text] [Related]
15. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma. Lvu W; Fei X; Chen C; Zhang B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165 [TBL] [Abstract][Full Text] [Related]
16. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
18. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X Front Immunol; 2022; 13():899710. PubMed ID: 35677036 [TBL] [Abstract][Full Text] [Related]
19. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma. Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939 [TBL] [Abstract][Full Text] [Related]
20. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices. Xia P; Li Q; Wu G; Huang Y J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]